Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Axogen, Inc. Director's Dealing 2017

Dec 14, 2017

32414_dirs_2017-12-13_5f934adb-699d-47df-b0d6-72b7441fbbc5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2017-12-06

Reporting Person: Grooms Jamie Mark (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-12-06 Common Stock S 21290 $26.22 Disposed 344317 Direct
2017-12-07 Common Stock S 33500 $26.47 Disposed 310817 Direct
2017-12-08 Common Stock S 31805 $26.37 Disposed 279012 Direct

Footnotes

F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $27.00. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2: These shares of common stock include 132,883 shares held by the Jamie Grooms Trust, of which Mr. Grooms is the trustee.

F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.95. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.15 to $26.70. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F5: These shares of common stock include 108,883 shares held by the Jamie Grooms Trust, of which Mr. Grooms is the trustee.

F6: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017.

F7: Amended as a result of 2,300 shares sold on December 7, 2017 inadvertently not being disclosed. Such December 7, 2017 transaction has been revised resulting in a change in the aggregate number of shares sold and the weighted average sale price for such day, along with change in holdings after the December 7 and 8, 2017 transactions.